ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
(b) Departure of Andrew Weil, Chief Accounting Officer
Andrew Weil, Teva's Chief Accounting Officer, will step down from his role as
Chief Accounting Officer, effective November 24, 2021.
(c) Appointment of Amir Weiss as Chief Accounting Officer
Amir Weiss, currently Vice President of Finance and Corporate Controller, was
promoted to Senior Vice President and Chief Accounting Officer, effective
November 24, 2021.
Mr. Weiss, 44, joined Teva in June 2012 and has served in several senior
finance-related positions, including Vice President Corporate Finance (October
2019 - November 2021) and VP Finance, International Markets (April 2014 -
October 2019). Prior to joining Teva, Mr. Weiss served as Corporate Controller
at RADCOM Ltd. from 2008 to 2012. From 2006 to 2008, he served as Corporate
Controller at Oblicore Inc. Mr. Weiss holds an MA in law, an MBA and a
Bachelor's degree in Economics and Accounting from Bar Ilan University.
Mr. Weiss is a Certified Public Accountant.
In connection with his promotion to Senior Vice President and Chief Accounting
Officer, Mr. Weiss's terms of employment were modified to increase his initial
base salary to 840,000 New Israeli Shekels, with eligibility to be considered
for an annual cash incentive with a target amount equal to 50% of his annual
base salary and for equity-based awards under the Company's equity compensation
plan.
Mr. Weiss does not have any family relationships with any of the Company's
directors or executive officers and is not party to any transactions required to
be disclosed under Item 404(a) of Regulation S-K.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses